Anna Francis1,2, David W Johnson3,4,5, Anette Melk6, Bethany J Foster7, Katrina Blazek8, Jonathan C Craig9, Germaine Wong8,10. 1. School of Public Health, University of Sydney, Sydney, New South Wales, Australia; anna.francis@health.qld.gov.au. 2. Child and Adolescent Renal Service, Children's Health Queensland, South Brisbane, Queensland, Australia. 3. Australasian Kidney Trials Network, University of Queensland, Queensland, Brisbane, Australia. 4. School of Medicine, Translational Research Institute, Queensland, Brisbane, Australia. 5. Department of Nephrology, Princess Alexandra Hospital, Queensland, Brisbane, Australia. 6. Department of Pediatric Nephrology, Hannover Medical School, Hannover, Germany. 7. Division of Nephrology, Department of Pediatrics, McGill University Faculty of Medicine, Montreal, Quebec, Canada. 8. School of Public Health, University of Sydney, Sydney, New South Wales, Australia. 9. School of Medicine, Flinders University, Adelaide, South Australia, Australia; and. 10. Centre for Transplant and Renal Research, Westmead Hospital, Westmead, New South Wales, Australia.
Abstract
BACKGROUND AND OBJECTIVES: Survival in pediatric kidney transplant recipients has improved over the past five decades, but changes in cause-specific mortality remain uncertain. The aim of this retrospective cohort study was to estimate the associations between transplant era and overall and cause-specific mortality for child and adolescent recipients of kidney transplants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data were obtained on all children and adolescents (aged <20 years) who received their first kidney transplant from 1970 to 2015 from the Australian and New Zealand Dialysis and Transplant Registry. Mortality rates were compared across eras using Cox regression, adjusted for confounders. RESULTS: A total of 1810 recipients (median age at transplantation 14 years, 58% male, 52% living donor) were followed for a median of 13.4 years. Of these, 431 (24%) died, 174 (40%) from cardiovascular causes, 74 (17%) from infection, 50 (12%) from cancer, and 133 (31%) from other causes. Survival rates improved over time, with 5-year survival rising from 85% for those first transplanted in 1970-1985 (95% confidence interval [95% CI], 81% to 88%) to 99% in 2005-2015 (95% CI, 98% to 100%). This was primarily because of reductions in deaths from cardiovascular causes (adjusted hazard ratio [aHR], 0.25; 95% CI, 0.08 to 0.68) and infections (aHR, 0.16; 95% CI, 0.04 to 0.70; both for 2005-2015 compared with 1970-1985). Compared with patients transplanted 1970-1985, mortality risk was 72% lower among those transplanted 2005-2015 (aHR, 0.28; 95% CI, 0.18 to 0.69), after adjusting for potential confounders. CONCLUSIONS: Survival after pediatric kidney transplantation has improved considerably over the past four decades, predominantly because of marked reductions in cardiovascular- and infection-related deaths.
BACKGROUND AND OBJECTIVES: Survival in pediatric kidney transplant recipients has improved over the past five decades, but changes in cause-specific mortality remain uncertain. The aim of this retrospective cohort study was to estimate the associations between transplant era and overall and cause-specific mortality for child and adolescent recipients of kidney transplants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data were obtained on all children and adolescents (aged <20 years) who received their first kidney transplant from 1970 to 2015 from the Australian and New Zealand Dialysis and Transplant Registry. Mortality rates were compared across eras using Cox regression, adjusted for confounders. RESULTS: A total of 1810 recipients (median age at transplantation 14 years, 58% male, 52% living donor) were followed for a median of 13.4 years. Of these, 431 (24%) died, 174 (40%) from cardiovascular causes, 74 (17%) from infection, 50 (12%) from cancer, and 133 (31%) from other causes. Survival rates improved over time, with 5-year survival rising from 85% for those first transplanted in 1970-1985 (95% confidence interval [95% CI], 81% to 88%) to 99% in 2005-2015 (95% CI, 98% to 100%). This was primarily because of reductions in deaths from cardiovascular causes (adjusted hazard ratio [aHR], 0.25; 95% CI, 0.08 to 0.68) and infections (aHR, 0.16; 95% CI, 0.04 to 0.70; both for 2005-2015 compared with 1970-1985). Compared with patients transplanted 1970-1985, mortality risk was 72% lower among those transplanted 2005-2015 (aHR, 0.28; 95% CI, 0.18 to 0.69), after adjusting for potential confounders. CONCLUSIONS: Survival after pediatric kidney transplantation has improved considerably over the past four decades, predominantly because of marked reductions in cardiovascular- and infection-related deaths.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Blanche M Chavers; Michelle N Rheault; Arthur J Matas; Scott C Jackson; Marie E Cook; Thomas E Nevins; John S Najarian; Srinath Chinnakotla Journal: Transplantation Date: 2018-02 Impact factor: 4.939
Authors: E Allain-Launay; G Roussey-Kesler; B Ranchin; G Guest; A Maisin; R Novo; J L André; S Cloarec; C Guyot Journal: Pediatr Transplant Date: 2009-09
Authors: Kenneth A Andreoni; Rachel Forbes; Regina M Andreoni; Gary Phillips; Heather Stewart; Maria Ferris Journal: JAMA Intern Med Date: 2013-09-09 Impact factor: 21.873
Authors: Bethany J Foster; Mark M Mitsnefes; Mourad Dahhou; Xun Zhang; Benjamin L Laskin Journal: Clin J Am Soc Nephrol Date: 2017-12-14 Impact factor: 8.237
Authors: Tracey Ying; Bree Shi; Patrick J Kelly; Helen Pilmore; Philip A Clayton; Steven J Chadban Journal: J Am Soc Nephrol Date: 2020-09-09 Impact factor: 10.121
Authors: Rizky Indrameikha Sugianto; Karen Ostendorf; Nima Memaran; Anette Melk; Elena Bauer; Jeannine von der Born; Jun Oh; Markus J Kemper; Rainer Buescher; Bernhard M W Schmidt Journal: Pediatr Nephrol Date: 2022-09-12 Impact factor: 3.651
Authors: Adan Z Becerra; Kevin E Chan; Paul W Eggers; Jenna Norton; Paul L Kimmel; Ivonne H Schulman; Susan R Mendley Journal: J Am Soc Nephrol Date: 2022-01-25 Impact factor: 14.978
Authors: Shaifali Sandal; JiYoon B Ahn; Marcelo Cantarovich; Nadia M Chu; Dorry L Segev; Mara A McAdams-DeMarco Journal: Transplantation Date: 2021-06-02 Impact factor: 5.385